Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043317-26-000004

Chief Commercial Officer acquired 168 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evans Terry L Chief Commercial Officer 2026-04-30 Option exercise +168 20,847 D
Loading xslF345X06/form4-05012026_040507.xml…